טוען...
4CPS-041 Drug survival of biologic therapies for the treatment of psoriasis
BACKGROUND: Biologic drug survival is defined as the time from initiation of biologic therapy to discontinuation, which can be due to ineffectiveness, adverse events or other reasons. It is an important measurement of overall treatment success in psoriasis and a priority in clinical practice. Clinic...
שמור ב:
| הוצא לאור ב: | Eur J Hosp Pharm |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMJ Group
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535264/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.132 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|